Proceedings of the National Academy of Sciences · 1999 · 387 citations · 29 references
MedicineGeneticsOncologyCarcinogenesisGenomicsTumor ProgressionCancer Genomic InstabilityCancer GenomicsCancer ProgressionColorectal CancerHereditary Cancer SyndromesMalignant NeoplasmsColonic PolypsGastrointestinal PolypsGenome Instability In CancerHereditary Colorectal Cancer SyndromesNeoplastic ProgressionSomatic Genomic AlterationsSporadic Colorectal CancerTumor Progression Dynamics
Cancer cell genomes contain alterations beyond known etiologic events, but their total number has been unknown at even the order of magnitude level. By sampling colorectal premalignant polyp and carcinoma cell genomes through use of the technique inter-(simple sequence repeat) PCR, we have found genomic alterations to be considerably more abundant than expected, with the mean number of genomic events per carcinoma cell totaling approximately 11,000. Colonic polyps early in the tumor progression pathway showed similar numbers of events. These results indicate that, as with certain hereditary cancer syndromes, genomic destabilization is an early step in sporadic tumor development. Together these results support the model of genomic instability being a cause rather than an effect of malignancy, facilitating vastly accelerated somatic cell evolution, with the observed orderly steps of the colon cancer progression pathway reflecting the consequences of natural selection.
29
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Michael S. O’Reilly, Thomas Boehm, Yuen Shing et al. · Cell · 1997 · 4.5K citations · Full text
Medicine, Oncology, Pharmacology +11
C. Richard Boland, Stephen N. Thibodeau, Stanley R. Hamilton et al. · PubMed · 1998 · 4.1K citations
Life Sciences, Genetics, Oncology +17